Conference Report--early Cancer Diagnosis: Beating the Odds

Overview

Journal MedGenMed

Specialty General Medicine

Date 2004 Nov 3

PMID 15520641

Citations 1

Authors

Sara M Mariani

Affiliations

Soon will be listed here.

Citing Articles

BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.

Friedenson B MedGenMed. 2005; 7(2):60.

PMID: 16369438 PMC: 1681605.

References

Rebbeck T, Friebel T, Lynch H, Neuhausen S, van t Veer L, Garber J . Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004; 22(6):1055-62. DOI: 10.1200/JCO.2004.04.188. View

Tutt A, Ashworth A . The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med. 2002; 8(12):571-6. DOI: 10.1016/s1471-4914(02)02434-6. View

Elledge S, Amon A . The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell. 2002; 1(2):129-32. DOI: 10.1016/s1535-6108(02)00041-7. View

McGinnis J, Williams-Russo P, Knickman J . The case for more active policy attention to health promotion. Health Aff (Millwood). 2002; 21(2):78-93. DOI: 10.1377/hlthaff.21.2.78. View

Goldie S, Grima D, Kohli M, Wright T, Weinstein M, Franco E . A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003; 106(6):896-904. DOI: 10.1002/ijc.11334. View

Li H, Giger M, Huo Z, Olopade O, Lan L, Weber B . Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location. Med Phys. 2004; 31(3):549-55. DOI: 10.1118/1.1644514. View

Levin B, Smith R, Feldman G, Colditz G, Fletcher R, Nadel M . Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer. 2002; 95(8):1618-28. DOI: 10.1002/cncr.10890. View

Venkitaraman A . Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene, BRCA2. Cold Spring Harb Symp Quant Biol. 2003; 65:567-72. DOI: 10.1101/sqb.2000.65.567. View

Bartek J, Lukas J . Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003; 3(5):421-9. DOI: 10.1016/s1535-6108(03)00110-7. View

10.

Olopade O, Artioli G . Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J. 2004; 10 Suppl 1:S5-9. DOI: 10.1111/j.1524-4741.2004.101s3.x. View

11.

Pickhardt P, Choi J, Hwang I, Butler J, Puckett M, Hildebrandt H . Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003; 349(23):2191-200. DOI: 10.1056/NEJMoa031618. View

12.

Levin B, Brooks D, Smith R, Stone A . Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003; 53(1):44-55. DOI: 10.3322/canjclin.53.1.44. View

13.

Foulkes W, Metcalfe K, Sun P, Hanna W, Lynch H, Ghadirian P . Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res. 2004; 10(6):2029-34. DOI: 10.1158/1078-0432.ccr-03-1061. View

14.

Rosen E, Fan S, Pestell R, Goldberg I . BRCA1 gene in breast cancer. J Cell Physiol. 2003; 196(1):19-41. DOI: 10.1002/jcp.10257. View

15.

Young G, St John D, Winawer S, Rozen P . Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002; 97(10):2499-507. DOI: 10.1111/j.1572-0241.2002.06046.x. View

16.

Seeff L, Nadel M, Klabunde C, Thompson T, Shapiro J, Vernon S . Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004; 100(10):2093-103. DOI: 10.1002/cncr.20276. View

17.

Wright Jr T, Schiffman M, Solomon D, Cox J, Garcia F, Goldie S . Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004; 103(2):304-9. DOI: 10.1097/01.AOG.0000109426.82624.f8. View

18.

Hawley S, Vernon S, Levin B, Vallejo B . Prevalence of colorectal cancer screening in a large medical organization. Cancer Epidemiol Biomarkers Prev. 2004; 13(2):314-9. DOI: 10.1158/1055-9965.epi-509-2. View

19.

Wright Jr T, Cox J, Massad L, Carlson J, Twiggs L, Wilkinson E . 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003; 189(1):295-304. DOI: 10.1067/mob.2003.633. View

20.

Park T, Fujiwara H, Wright T . Molecular biology of cervical cancer and its precursors. Cancer. 1995; 76(10 Suppl):1902-13. DOI: 10.1002/1097-0142(19951115)76:10+<1902::aid-cncr2820761306>3.0.co;2-0. View